| Deidre Dann, RN | |
|
36 Hampton Ter, Orange, NJ 07050-3904 | |
| (862) 520-1165 | |
| Not Available |
| Full Name | Deidre Dann |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Community Health |
| Location | 36 Hampton Ter, Orange, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982061016 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1500X | Registered Nurse - Community Health | 26NR159341000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deidre Dann, RN 36 Hampton Terrarce, Orange, NJ 07050 Ph: (862) 520-1165 | Deidre Dann, RN 36 Hampton Ter, Orange, NJ 07050-3904 Ph: (862) 520-1165 |
News Archive
The idea seemed transformative. The Affordable Care Act would fund a new research outfit evocatively named the Innovation Center to discover how to most effectively deliver health care, with $10 billion to spend over a decade.
Ceregene, a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.
New biotechnology company, RiboNovix, Inc., is addressing the worsening problem of antibiotic-resistant bacteria by developing new anti-infectives that are less susceptible to drug resistance.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.
In a new study, investigators found that ideal cardiovascular health, which is indicative of a healthy lifestyle, was associated with lower odds for ocular diseases especially diabetic retinopathy.
› Verified 8 days ago
Prince Asmah, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 497 Linden Pl Apt 201, Orange, NJ 07050 Phone: 973-393-6031 | |
Chantal Tanisha Marie Wilson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 765 Vose Ave, Apt B10, Orange, NJ 07050 Phone: 973-943-3728 | |
Love Philippe, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 280 Central Ave Apt 405, Orange, NJ 07050 Phone: 973-666-6487 | |
Ntozake Escourse, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 558 Mcchesney St Unit 1, Orange, NJ 07050 Phone: 347-633-5550 | |
Mr. Stephen A Adjei, FNP, NP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 248 Reynolds Ter Apt 4n, Orange, NJ 07050 Phone: 973-413-0235 |